Pathophysiology of multiple sclerosis;Physiopathologie de la sclérose en plaques

Presse Medicale

Volumn 39, Issue 3, 2010, Pages 341-348

  Brassat, David ^a  

^a CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE COURSE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; MULTIPLE SCLEROSIS; PATHOGENESIS; PATHOPHYSIOLOGY; SHORT SURVEY;

HUMANS; MULTIPLE SCLEROSIS;

EID: 77949539649     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2009.12.001     Document Type: Short Survey

References (17)

1. Confavreux C., Vukusic S. Natural history of multiple sclerosis: a unifying concept. Brain 2006, 129:606-616.
2. Ebers G.C. Environmental factors and multiple sclerosis. Lancet Neurol 2008, 7:268-277.
3. Jersild C., Svejgaard A., Fog T. HL-A antigens and multiple sclerosis. Lancet 1972, 1:1240-1241.
4. Oksenberg J.R., Baranzini S.E., Sawcer S., Hauser S.L. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet 2008, 9:516-526.
5. Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., De Jager P.L., et al. Risk alleles for multiple sclerosis identified by a genome wide study. N Engl J Med 2007, 357:851-862.
6. Gregory S.G., Schmidt S., Seth P., Oksenberg J.R., Hart J., Prokop A., et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 2007, 39:1083-1091.
7. Lundmark F., Duvefelt K., Iacobaeus E., Kockum I., Wallström E., Khademi M., et al. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 2007, 39:1108-1113.
8. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Genome-wide association study identifies new multiple sclerosis susceptibilityloci on chromosomes 12 and 20. Nat Genet 2009;41:824-8.
9. De Jager P.L., Jia X., Wang J., de Bakker P.I., Ottoboni L., Aggarwal N.T., et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 2009, 41:776-782.
10. Lyons D.A., Naylor S.G., Scholze A., Talbot W.S. Kif1b is essential for mRNA localization in oligodendrocytes and development of myelinated axons. Nat Genet 2009, 41:854-858.
11. Ascherio A. Epstein-Barr virus in the development of multiple sclerosis. Expert Rev Neurother 2008, 8:331-333.
12. Ramagopalan S.V., Maugeri N.J., Handunnetthi L., Lincoln M.R., Orton S.M., Dyment D.A., et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet 2009, 5:e1000369.
13. Correale J., Ysrraelit M.C., Gaitán M.I. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 2009, 132:1146-1160.
14. Hawkes C.H. Smoking is a risk factor for multiple sclerosis: a metanalysis. Mult Scler 2007, 13:610-615.
15. http://www.arsep.org/%3Fmod=actualite%26ID=100%26lang=fr.
16. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002, 347:911-920.
17. Correale J., Farez M., Razzitte G. Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann Neurol 2008, 64:187-199.